DIGIANDOMENICO ANTHONY 13D/13G Filings for Cue Biopharma, Inc. (CUE)

DIGIANDOMENICO ANTHONY 13D and 13G filings for Cue Biopharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2023-08-01
5:19 pm
Purchase
2021-07-25 13D Cue Biopharma, Inc.
CUE
DIGIANDOMENICO ANTHONY 6,251,645
22.600%
6,251,645increase
(New Position)
Filing